4.3 Article

Improving the diagnostic accuracy of a stratified screening strategy by identifying the optimal risk cutoff

Journal

CANCER CAUSES & CONTROL
Volume 30, Issue 10, Pages 1145-1155

Publisher

SPRINGER
DOI: 10.1007/s10552-019-01208-9

Keywords

Cancer screening; Stratified screening; Risk assessment; ROC analysis

Funding

  1. Lundbeckfonden, National Cancer Institute [5K07CA088811, 1R03CA136048-01A1]
  2. National Institute of Dental and Craniofacial Research [RC2DE020779]

Ask authors/readers for more resources

Background The American Cancer Society (ACS) suggests using a stratified strategy for breast cancer screening. The strategy includes assessing risk of breast cancer, screening women at high risk with both MRI and mammography, and screening women at low risk with mammography alone. The ACS chose their cutoff for high risk using expert consensus. Methods We propose instead an analytic approach that maximizes the diagnostic accuracy (AUC/ROC) of a risk-based stratified screening strategy in a population. The inputs are the joint distribution of screening test scores, and the odds of disease, for the given risk score. Using the approach for breast cancer screening, we estimated the optimal risk cutoff for two different risk models: the Breast Cancer Screening Consortium (BCSC) model and a hypothetical model with much better discriminatory accuracy. Data on mammography and MRI test score distributions were drawn from the Magnetic Resonance Imaging Screening Study Group. Results A risk model with an excellent discriminatory accuracy (c-statistic =0.947 yielded a reasonable cutoff where only about 20% of women had dual screening. However, the BCSC risk model (c-statistic =0.631 lacked the discriminatory accuracy to differentiate between women who needed dual screening, and women who needed only mammography. Conclusion Our research provides a general approach to optimize the diagnostic accuracy of a stratified screening strategy in a population, and to assess whether risk models are sufficiently accurate to guide stratified screening. For breast cancer, most risk models lack enough discriminatory accuracy to make stratified screening a reasonable recommendation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available